Dr. Matthew Samuel Fine, MD

Dr. Fine practices at Baptist Health Endoscopy Center at Coral Springs in Coral Springs, Florida.

Dr. Fine's NPI, 1164686606, was assigned on July 14, 2008. Dr. Fine graduated from University of Miami, Miller School of Medicine in 2006. Dr. Fine holds Florida license ME 109795.

Dr. Fine's primary practice is Baptist Health Endoscopy Center at Coral Springs, at 3001 Coral Hills Dr, Ste 200, Coral Springs, FL 33065. The practice phone is (954) 837-1202.

Dr. Fine's primary practice is Baptist Health Endoscopy Center at Coral Springs in Coral Springs, Florida. Dr. Fine is also affiliated with Memorial Hospital West. The medical group on file is South Florida Surgical Specialists. Dmand AI also links Dr. Fine to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fine practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Fine's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Fine is board certified in urology by the American Board of Urology. Dr. Fine is licensed in Florida.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney stone disease, prostate cancer and testicular dysfunction among the conditions Dr. Fine treats.

CMS data shows 541 Medicare services from Dr. Fine across 10 procedure codes in 2024, for 191 Medicare patients. Medicare paid $35,156 for them.

CMS counts 191 Medicare patients who saw Dr. Fine in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fine's median patient age at 64, with 29% women.

In 2024, Dr. Fine wrote 1,062 Medicare Part D claims for 251 patients. 93% of them were for generic drugs. CMS names the drug for 941 of them, across 20 drugs with 11 or more claims each, at $63,770 in total drug cost. In 2023, CMS named 799 claims across 20 drugs.

Dr. Fine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fine as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Fine in 2011.

CMS Open Payments shows 113 general payments to Dr. Fine from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Rochester Medical Corporation paid the most, $599.

Dr. Fine graduated from University of Miami, Miller School of Medicine in 2006. Dr. Fine is a member of AUA, GURS - Society of Genitorurinary Reconstructive Surgeons and SUFU - Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction.

Dr. Fine is in network with 16 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.